BRKR
Bruker Corp

850
Mkt Cap
$6.98B
Volume
727,794.00
52W High
$56.22
52W Low
$28.53
PE Ratio
-268.26
BRKR Fundamentals
Price
$40.21
Prev Close
$39.89
Open
$40.03
50D MA
$45.84
Beta
1.12
Avg. Volume
2.66M
EPS (Annual)
-$0.1482
P/B
2.48
Rev/Employee
$301,553.18
$8,758.40
Loading...
Loading...
News
all
press releases
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages
Bruker Corporation (NASDAQ:BRKR - Get Free Report) has been given an average rating of "Hold" by the fifteen brokerages that are presently covering the firm, Marketbeat reports. Two investment...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape XR, a next-generation spatial proteomics platform designed to advance the development of diagnostic and prognostic assays by...
Business Wire·1d ago
News Placeholder
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
Bruker Spatial Biology, a division of Bruker Corporation (Nasdaq: BRKR) announced today that it will expand its collaboration with Noetik Inc., following their prior study of more than 3500 patient...
Business Wire·2d ago
News Placeholder
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
Bruker Corporation (Nasdaq: BRKR) announced today significant portfolio advancements from Bruker Spatial Biology to be unveiled at the 2026 Advances in Genome Biology and Technology (AGBT) General...
Business Wire·3d ago
News Placeholder
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni mass spectrometer to enable disease researchers to move beyond...
Business Wire·3d ago
News Placeholder
EDENTREE ASSET MANAGEMENT Ltd Increases Position in Bruker Corporation $BRKR
EDENTREE ASSET MANAGEMENT Ltd grew its position in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 45.5% during the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·4d ago
News Placeholder
Envestnet Asset Management Inc. Sells 43,490 Shares of Bruker Corporation $BRKR
Envestnet Asset Management Inc. decreased its stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 13.9% during the third quarter, according to its most recent filing with the SEC...
MarketBeat·6d ago
News Placeholder
Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the Stock
Examine the evolution of Bruker's (BRKR) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Zacks·8d ago
News Placeholder
Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down
BRKR's Q4 EPS miss estimates as margins plunge and shares fall 2.7% despite a revenue beat, while the 2026 outlook targets 4%-5% sales growth.
Zacks·10d ago
News Placeholder
M&G PLC Purchases 766,992 Shares of Bruker Corporation $BRKR
M&G PLC raised its position in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 233.0% in the third quarter, according to the company in its most recent filing with the Securities...
MarketBeat·10d ago
<
1
2
...
>

Latest BRKR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.